North West HTMR

A new centre will investigate how to make clinical trials more reliable, efficient, and patient-focused. Randomised controlled trials are the gold standard for comparing treatments, but they come with practical challenges. Early-stage drug testing must proceed through careful phases, and later-stage trials require researchers to decide which outcomes matter most—a choice that should balance clinical priorities with what patients actually care about. Currently, there is no dedicated hub where these methodological problems are systematically studied and solved. This centre will bring together experts to research the design, conduct, and analysis of clinical trials. It will address questions such as how to stage drug development efficiently and how to select meaningful outcome measures that reflect both medical and patient perspectives. The goal is to strengthen the evidence base that underpins healthcare decisions. If successful, the centre could improve the quality of clinical trials across the UK, leading to more trustworthy comparisons of treatments. Patients would benefit indirectly, because doctors would have better evidence to guide prescribing, surgery, or other care. The work targets the infrastructure of medical research itself—the quiet machinery that determines whether a new drug truly works—rather than any single disease or therapy.